Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
Is a |
Dinoprostone-containing product in parenteral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Prostaglandin PGE>2< |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Prostaglandin E>1< preparation (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dinoprostone (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Posterior pituitary hormone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
Has manufactured dose form |
Injection (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Prostaglandin E1 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
Has manufactured dose form |
Infusion concentrate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|